Aperio Group LLC boosted its position in shares of Orthofix International N.V. (NASDAQ:OFIX) by 12.6% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 17,240 shares of the medical device company’s stock after acquiring an additional 1,924 shares during the quarter. Aperio Group LLC owned about 0.09% of Orthofix International worth $815,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently modified their holdings of OFIX. Vanguard Group Inc. increased its stake in Orthofix International by 18.6% during the 1st quarter. Vanguard Group Inc. now owns 1,815,948 shares of the medical device company’s stock worth $69,278,000 after buying an additional 284,482 shares in the last quarter. Dimensional Fund Advisors LP grew its position in shares of Orthofix International by 11.6% in the second quarter. Dimensional Fund Advisors LP now owns 870,120 shares of the medical device company’s stock valued at $40,443,000 after purchasing an additional 90,349 shares in the last quarter. State Street Corp grew its position in shares of Orthofix International by 4.1% in the second quarter. State Street Corp now owns 481,220 shares of the medical device company’s stock valued at $22,370,000 after purchasing an additional 18,741 shares in the last quarter. Northern Trust Corp grew its position in shares of Orthofix International by 5.8% in the second quarter. Northern Trust Corp now owns 350,019 shares of the medical device company’s stock valued at $16,269,000 after purchasing an additional 19,253 shares in the last quarter. Finally, Teachers Advisors LLC grew its position in shares of Orthofix International by 15.9% in the second quarter. Teachers Advisors LLC now owns 320,404 shares of the medical device company’s stock valued at $14,892,000 after purchasing an additional 44,064 shares in the last quarter. 94.61% of the stock is owned by institutional investors.
Shares of Orthofix International N.V. (OFIX) traded up $0.83 during trading hours on Thursday, reaching $53.10. 95,577 shares of the company were exchanged, compared to its average volume of 147,885. The firm has a market capitalization of $961.14, a P/E ratio of 34.46, a P/E/G ratio of 2.61 and a beta of 0.14. Orthofix International N.V. has a 1 year low of $32.51 and a 1 year high of $54.73.
Orthofix International (NASDAQ:OFIX) last announced its quarterly earnings data on Monday, October 30th. The medical device company reported $0.42 EPS for the quarter, beating the Zacks’ consensus estimate of $0.41 by $0.01. Orthofix International had a net margin of 0.33% and a return on equity of 10.26%. The firm had revenue of $105.30 million during the quarter, compared to the consensus estimate of $100.67 million. During the same quarter last year, the firm earned $0.36 earnings per share. The firm’s revenue was up 6.9% compared to the same quarter last year. analysts anticipate that Orthofix International N.V. will post 1.61 EPS for the current year.
A number of research analysts recently commented on OFIX shares. TheStreet cut Orthofix International from a “b” rating to a “c+” rating in a report on Tuesday, October 31st. Zacks Investment Research cut Orthofix International from a “buy” rating to a “hold” rating in a research note on Wednesday, November 8th. BTIG Research set a $56.00 price target on Orthofix International and gave the stock a “buy” rating in a research note on Monday, October 30th. BidaskClub raised Orthofix International from a “hold” rating to a “buy” rating in a research report on Thursday, August 17th. Finally, Jefferies Group reaffirmed a “buy” rating and set a $55.00 price objective (up previously from $50.00) on shares of Orthofix International in a research report on Thursday, August 10th. One equities research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $54.42.
In other Orthofix International news, CFO Rice Doug sold 7,353 shares of Orthofix International stock in a transaction that occurred on Monday, September 11th. The shares were sold at an average price of $49.46, for a total value of $363,679.38. Following the completion of the sale, the chief financial officer now directly owns 44,743 shares of the company’s stock, valued at approximately $2,212,988.78. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Luke T. Faulstick sold 4,800 shares of Orthofix International stock in a transaction that occurred on Monday, November 6th. The stock was sold at an average price of $51.22, for a total transaction of $245,856.00. Following the completion of the sale, the director now directly owns 7,729 shares of the company’s stock, valued at $395,879.38. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 24,109 shares of company stock valued at $1,220,840. Insiders own 5.60% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This story was first reported by The Lincolnian Online and is owned by of The Lincolnian Online. If you are accessing this story on another domain, it was illegally stolen and republished in violation of United States & international trademark & copyright laws. The original version of this story can be accessed at https://www.thelincolnianonline.com/2017/12/07/aperio-group-llc-increases-stake-in-orthofix-international-n-v-ofix-updated-updated-updated.html.
Orthofix International Company Profile
Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.
Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with MarketBeat.com's FREE daily email newsletter.